VivoSeq
Other

Menorrhagia

17

Pipeline Programs↗

0

Active Trials↗

7

Companies Involved↗

Menorrhagia is an emerging landscape with 17 programs across 7 companies. The most active players are Eli Lilly, Bayer, Sumitomo Pharma America, Inc.. 6 therapies are approved with 2 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

43/100

Pipeline Velocity

0/100

Mech. Concentration

29/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Eli Lilly logo

Eli Lilly

1 program

Phase 3Bayer logo

Bayer

7 programs

Phase 3Sumitomo Pharma America, Inc. logo

Sumitomo Pharma America, Inc.

1 program

ApprovedSanofi logo

Sanofi

1 program

ApprovedA

Amring

1 program

ApprovedPfizer logo

Pfizer

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

13

clinical trials

Completed12 · 92%
Unknown status1 · 8%

Clinical Trials

Trial Activity

13 trials

Efficacy and Safety Study of XP12B in Women With Menorrhagia
Completed·Ferring logoFerring·Phase 3·NCT00386308·196 enrolled
Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia
Completed·—·Phase 4·NCT01165307·77 enrolled
Menorrhagia Study in Women With Treatment-resistant Menorrhagia
Completed·Bayer logoBayer·Phase 2·NCT00288691·26 enrolled
Efficacy of Combined Contraceptive Vaginal Ring(NuvaRing)in Women With Idiopathic Menorrhagia
Completed·MMansoura University·N/A·NCT01266759·95 enrolled
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
Completed·Bayer logoBayer·Phase 3·NCT00360490·165 enrolled
The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders
Completed·—·Phase 4·NCT00904709·249 enrolled
Efficacy and Safety of XP12B in Women With Menorrhagia
Completed·Ferring logoFerring·Phase 3·NCT00401193·304 enrolled
Trial of Homeopathy on Management of Menorrhagia
Completed·NNMP Medical Research Institute·N/A·NCT01460043·25 enrolled
MiCo - Mirena or Conventional Medical Treatment for Menorrhagia
Completed·Bayer logoBayer·N/A·NCT01085487·1,211 enrolled
Mirena in Idiopathic Menorrhagia
Completed·Bayer logoBayer·N/A·NCT00868153·1,125 enrolled
Safety Study of XP12B in Women With Menorrhagia
Completed·Ferring logoFerring·Phase 3·NCT00113568·784 enrolled
Mirena or Conventional Medical Treatment for Menorrhagia
Completed·Bayer logoBayer·N/A·NCT00864136·647 enrolled
Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD
Unknown status·—·Phase 1/2·NCT02616731·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)